196 related articles for article (PubMed ID: 3487319)
1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes.
Di Monte D; Jewell SA; Ekström G; Sandy MS; Smith MT
Biochem Biophys Res Commun; 1986 May; 137(1):310-5. PubMed ID: 3487319
[TBL] [Abstract][Full Text] [Related]
2. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes.
Di Monte D; Ekström G; Shinka T; Smith MT; Trevor AJ; Castagnoli N
Chem Biol Interact; 1987; 62(2):105-16. PubMed ID: 3496169
[TBL] [Abstract][Full Text] [Related]
3. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes.
Di Monte D; Sandy MS; Blank L; Smith MT
Biochem Biophys Res Commun; 1988 Jun; 153(2):734-40. PubMed ID: 3260098
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
Kass GE; Wright JM; Nicotera P; Orrenius S
Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
[TBL] [Abstract][Full Text] [Related]
5. MPTP and MPTP analogs induced cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites.
Singh Y; Swanson E; Sokoloski E; Kutty RK; Krishna G
Toxicol Appl Pharmacol; 1988 Nov; 96(2):347-59. PubMed ID: 3143167
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the mitochondrial transmembrane potential, ATP concentration, and cytotoxicity in isolated rat hepatocytes.
Wu EY; Smith MT; Bellomo G; Di Monte D
Arch Biochem Biophys; 1990 Nov; 282(2):358-62. PubMed ID: 2122806
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
Ransom BR; Kunis DM; Irwin I; Langston JW
Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
[TBL] [Abstract][Full Text] [Related]
8. Comparative toxicity and antioxidant activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B-generated metabolites in isolated hepatocytes and liver microsomes.
Ekström G; Di Monte D; Sandy MS; Smith MT
Arch Biochem Biophys; 1987 May; 255(1):14-8. PubMed ID: 3496045
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine inhibits proton motive force in energized liver mitochondria.
Singh Y; Bhatnagar R; Sidhu GS; Batra JK; Krishna G
Arch Biochem Biophys; 1989 May; 271(1):217-22. PubMed ID: 2540715
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes.
Smith MT; Ekström G; Sandy MS; Di Monte D
Life Sci; 1987 Feb; 40(8):741-8. PubMed ID: 3492653
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine delays the killing of cultured hepatocytes by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Snyder JW; Kyle ME; Ferraro TN
Arch Biochem Biophys; 1990 Jan; 276(1):132-8. PubMed ID: 2297220
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
Cheeseman AJ; Clark JB
J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694
[TBL] [Abstract][Full Text] [Related]
13. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
Kinemuchi H; Arai Y; Toyoshima Y
Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity.
Di Monte D; Sandy MS; Ekström G; Smith MT
Biochem Biophys Res Commun; 1986 May; 137(1):303-9. PubMed ID: 3487318
[TBL] [Abstract][Full Text] [Related]
15. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
Irwin I; Langston JW
Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
17. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
Riachi NJ; LaManna JC; Harik SI
J Pharmacol Exp Ther; 1989 Jun; 249(3):744-8. PubMed ID: 2786562
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
20. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
